tm logo
OQIRZA
Live/Pending
PUBLISHED FOR OPPOSITION

on 12 Nov 2024

Last Applicant/ Owned by

Serial Number

79378149 filed on 18th Jul 2023

Registration Number

N/A

Correspondent Address

Max Moskowitz

Max Moskowitz OSTROLENK FABER LLP

Binger Str. 173

New York, NY 10022

United States

Filing Basis

1. filing basis filed as 66 a

Disclaimer

NO DATA

OQIRZA

Pharmaceutical preparations for the prevention and treatment of diseases and disorders of the alimentary tract and metabolism; pharmaceutical preparations for the prevention and treatment of diseases and disorders and of the blood and blood forming organs; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the cardiovascular system, musculoskeletal system, ce Read More

Classification Information


Class [005]
Pharmaceutical Products


Pharmaceutical preparations for the prevention and treatment of diseases and disorders of the alimentary tract and metabolism; pharmaceutical preparations for the prevention and treatment of diseases and disorders and of the blood and blood forming organs; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system, genitourinary system and respiratory system; pharmaceutical preparations for the prevention and treatment of dermatological diseases and disorders, damaged skin and tissues; pharmaceutical preparations for the prevention and treatment of inflammation and inflammatory diseases and disorders; pharmaceutical preparations for the prevention and treatment of ophthalmological diseases and disorders; pharmaceutical preparations for the treatment and prevention of hormonal diseases and disorders; pharmaceutical preparations for the treatment and prevention of infectious diseases and disorders and viral infections; pharmaceutical preparations for the prevention and treatment of oncological and auto-immune diseases and disorders; pharmaceutical preparations, namely, cell based immune therapeutics for treatment of cancer, for treatment of immunological diseases, and treatment of infectious diseases


First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details


Serial Number

No 79378149

Mark Type

No Service/Collective Mark

Attorney Docket Number

No TE/3974-1030

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

Yes

66A Current

Yes

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
12th Nov 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12th Nov 2024PUBLISHED FOR OPPOSITION
23rd Oct 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01st Oct 2024APPROVED FOR PUB - PRINCIPAL REGISTER
27th Sep 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
27th Sep 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
27th Sep 2024TEAS/EMAIL CORRESPONDENCE ENTERED
24th Apr 2024REFUSAL PROCESSED BY IB
29th Mar 2024NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
29th Mar 2024REFUSAL PROCESSED BY MPU